To examine if the observed TUC effects are restricted to HER2-overexpressing cell lines, the metabolic activity was also measured in HER2-negative BC cell lines HCC38 (n = 2) and MCF7 (n = 3). This evidence concerns the gene ERBB2 and breast cancer.